Document:

Filed by Bowne Pure Compliance

Exhibit 10.1

SXC HEALTH SOLUTIONS CORP. AMENDED

AND RESTATED 2000 RESTRICTED STOCK GRANT PLAN

1.     Purpose. The SXC Health Solutions Corp. Amended and Restated 2000 Restricted Stock Grant Plan (the
“Plan”) is intended to advance the interests of SXC Health Solutions Corp., a corporation organized under the laws of
the Yukon Territory, Canada (the “Company”), by encouraging and enabling eligible employees, non-employee directors,
consultants and advisors, upon whose judgment, initiative and effort the Company is largely dependent for the
successful conduct of its business, to acquire and retain a proprietary interest in the Company by ownership of its
Common Shares. The Company assumed the Plan in connection with the acquisition of National Medical Health Card
Systems, Inc., a Delaware corporation (“NMHC”), on April 30, 2008. The Plan has been amended and restated to limit the
Grants that may be made pursuant to the rules of the Nasdaq Stock Exchange.

2.     Definitions. For purposes of the Plan, the following terms shall have the indicated meanings unless the
context clearly indicates otherwise:

        “Board” means the Board of Directors of the Company.

        “Code” means the Internal Revenue Code of 1986, as it may be amended from time to time.

        “Committee” means the Compensation Committee of the Board; provided that the full Board may perform any
function of the Committee hereunder, in which case the term “Committee” shall refer to the Board.

        “Common Share” means the Company’s Common Shares, no par value per share.

        “Exchange Act” means the Securities Exchange Act of 1934, as it may be amended from time to time.

        “Grant” means a grant of unrestricted Shares, Restricted Stock or Restricted Stock Units to a Participant
pursuant to the Plan.

        “Participants” means the employees and non-employee directors of, or consultants and advisors to, the
Company or any of its affiliates; provided, however, the term “Participants” shall not include any such consultant or
advisor unless (i) the consultant or advisor is a natural person (or an entity wholly-owned by the consultant or
advisor), (ii) bona fide services have been or are to be rendered by such consultant or advisor and (iii)
such services are not in connection with the offer or sale of securities in a capital raising transaction and do not
directly or indirectly promote or maintain a market for the Company’s securities. For purposes hereof, a non-employee
to whom an offer of employment has been extended shall be considered an employee.

        “Performance Goals” shall mean the performance goals established by the Committee in connection with a
Grant to a Participants under Section 8(d).

        “Performance Period” shall mean the period established by the Committee for measuring whether, and to what
extent, any Performance Goals established in connection with any Grant under Section 8(d) hereof have been met.

        “Plan” means this SXC Health Solutions Corp. Amended and Restated 2000 Restricted Stock Grant Plan.

        “Qualified Member” means a member of the Committee who is a “non-employee director” within the meaning of
Rule 16b-3(b)(3) under Section 16 of the Exchange Act and an “outside director” within the meaning of Regulation
1.162-27 under Section 162(m) of the Code.

        “Restricted Stock” means a Grant of Shares to a Participant under Section 8(b) which is subject to certain
restrictions and to a risk of forfeiture.

        “Restricted Stock Unit” means a Grant of a right to a Participant under Section 8(c) to receive Shares in
the future which is subject to certain restrictions and to a risk of forfeiture.

        “Shares” means shares of Common Shares which are granted to a Participant pursuant to a Grant under the
Plan.

3.     Administration.

(a)     Authority. The Plan will be administered by the Committee. The Committee shall have full and final
authority in its discretion, subject to the provisions of the Plan, (a) to determine the Participants, the time or
times at which Grants shall be made and the number of Shares so granted; (b) to construe and interpret the Plan; (c) to
determine the terms, restrictions and provisions of the respective Grants, which need not be identical, including, but
without limitation, restrictions on Shares granted and the amount and terms of the purchase price, if any, of Shares
granted; and (d) to make all other determinations and take all other actions deemed necessary or advisable for the
proper administration of the Plan. All such actions and determinations shall be final, binding and conclusive for all
purposes and upon all persons. No action of the Committee shall be void or deemed to be without authority due to the
failure of any member, at the time the action was taken, to meet any qualification standard set forth in the Plan. To
the fullest extent authorized under the laws of the Yukon territory, the Committee may delegate to officers or managers
of the Company or any affiliate, or committees thereof, the authority, subject to such terms as the Committee shall
determine, to perform such functions, including administrative functions, as the Committee may determine, to the extent
that such delegation will not cause Grants intended to qualify as “performance-based compensation” under Code Section
162(m) or intended to qualify for an exemption under Rule 16b-3 under the Exchange Act to fail to so qualify.

 

1

 

(b)     Manner of Exercise of Authority. At any time that a member of the Committee is not a Qualified Member,
any action of the Committee relating to a Grant intended by the Committee to qualify as “performance-based
compensation” within the meaning of Code Section 162(m) or intended to be covered by an exemption under Rule 16b-3
under the Exchange Act may be taken by a subcommittee, designated by the Committee or the Board, composed solely of two
or more Qualified Members or may be taken by the Committee but with each such member who is not a Qualified Member
abstaining or recusing himself or herself from such action, provided that, upon such abstention or recusal, the
Committee remains composed of two or more Qualified Members. Such action, authorized by such a subcommittee or by the
Committee upon the abstention or recusal of such non-Qualified Member(s), shall be the action of the Committee for
purposes of the Plan.

(c)     Limitation of Liability. The Committee and each member thereof, and any person acting pursuant to
authority delegated by the Committee, shall be entitled, in good faith, to rely or act upon any report or other
information furnished by any executive officer, other officer or employee of the Company or an affiliate, the Company’s
independent auditors, consultants or any other agents assisting in the administration of the Plan. Members of the
Committee, any person acting pursuant to authority delegated by the Committee, and any officer or employee of the
Company or an affiliate acting at the direction or on behalf of the Committee or a delegee shall not be personally
liable for any action or determination taken or made in good faith with respect to the Plan, and shall, to the extent
permitted by law, be fully indemnified and protected by the Company with respect to any such action or determination.

4.     Number of Shares Subject to the Plan. The total number of Shares available for Grants under the Plan may
not exceed in the aggregate 166,123, subject to adjustment upon occurrence of any of the events indicated in Section 6
hereof. The Shares to be delivered under the Grants may consist, in whole or in part, of authorized but unissued Common
Shares or treasury Common Shares not reserved for any other purpose. If a Grant, or any portion thereof, is forfeited
for any reason, any Shares forfeited or potentially issuable under such Grant shall be available again for the making
of a later Grant hereunder.

5.     Individual Grant Limitation. With respect to Grants that are intended to qualify as “performance-based
compensation” under Code Section 162(m), the maximum number of shares of Common Shares which may be subject to Grants
under the Plan made to any Participant during any calendar year shall not exceed 150,000, subject to adjustment upon
occurrence of any of the events indicated in Section 6 hereof.

6.     Adjustment in Capitalization. In the event of any change in the outstanding Common Shares by reason of a
stock dividend, stock split, reorganization, reclassification, recapitalization, merger, consolidation, combination,
exchange of shares, or other similar change, then the aggregate number and class of shares or other securities that may
be issued or transferred pursuant to the Plan and the individual grant limitation specified in Section 5 hereof, and
the provisions, terms and conditions of each outstanding Grant affected thereby, shall be adjusted appropriately by the
Committee, whose determination shall be conclusive.

7.     Eligibility and Participation. The Committee, in its sole discretion, but subject to the provisions of
the Plan, shall determine the Participants to whom Grants shall be granted, and the number of shares to be covered by
each Grant, taking into account the nature of the employment or services rendered by the individuals or entities being
considered, their annual compensation, their present and potential contributions to the success of the Company, and
such other factors as the Committee may deem relevant.

8.     Specific Terms of Grants.

(a)     General. Subject to the provisions of Section 7, the Committee, may make grants to employees and
officers of NMHC as the Committee shall determine on the terms and conditions set forth in this Section 8. Each Grant
shall be made pursuant to a written instrument which must be executed by the Participant in order to be effective. The
Committee may impose on any Grant such additional terms and conditions, not inconsistent with the provisions of the
Plan, as the Committee shall determine, including terms requiring forfeiture of Grants in the event of termination of
employment or service by the Participant and terms permitting a Participant to make elections relating to his or her
Grant. The Committee shall require the payment of lawful consideration for a Grant to the extent necessary to satisfy
the requirements of applicable law, and may otherwise require payment of consideration for a Grant.

(b)     Grants of Restricted Stock. The Committee is authorized to grant Restricted Stock to Participants on
the following terms and conditions:

(i)     Restricted Stock shall be subject to such restrictions on transferability, risk of forfeiture and other
restrictions, if any, as the Committee may impose, which restrictions may lapse separately or in combination at such
times, under such circumstances (including based on achievement of performance goals and/or future service
requirements), in such installments or otherwise and under such other circumstances as the Committee may determine at
the date of grant or thereafter. Except to the extent restricted under the terms of the Plan and any Grant instrument,
a Participant granted Restricted Stock shall have all of the rights of a stockholder, including the right to vote the
Restricted Stock and the right to receive dividends thereon (subject to any mandatory reinvestment or other requirement
imposed by the Committee).

(ii)     Except as otherwise determined by the Committee, upon termination of employment or service during the
applicable restriction period, Restricted Stock that is at that time subject to restrictions shall be forfeited and
reacquired by the Company; provided that the Committee may provide, by rule or regulation or in any Grant instrument,
or may determine in any individual case, that restrictions or forfeiture conditions relating to Restricted Stock will
lapse in whole or in part, including in the event of terminations resulting from specified causes.

(iii)     Restricted Stock granted under the Plan may be evidenced in such manner as the Committee shall determine. If
certificates representing Restricted Stock are registered in the name of the Participant, the Committee may require
that such certificates bear an appropriate legend referring to the terms, conditions and restrictions applicable to
such Restricted Stock, that the Company retain physical possession of the certificates, and that the Participant
deliver a stock power to the Company, endorsed in blank, relating to the Restricted Stock.

 

2

 

(iv)     As a condition to the receipt of a Grant of Restricted Stock, the Committee may require that any dividends
paid on a share of Restricted Stock shall be (A) paid with respect to such Restricted Stock at the dividend payment
date in cash, in kind, or in unrestricted Shares, or (B) automatically reinvested in additional Restricted Stock or
held in kind, which shall be subject to the same terms as applied to the original Restricted Stock to which it relates,
or (C) deferred as to payment, either as a cash deferral or with the amount or value thereof automatically deemed
reinvested in shares of Restricted Stock, subject to such terms as the Committee shall determine or permit a
Participant to elect. Unless otherwise determined by the Committee, Stock distributed in connection with a Stock split
or Stock dividend, and other property distributed as a dividend, shall be subject to restrictions and a risk of
forfeiture to the same extent as the Restricted Stock with respect to which such Stock or other property has been
distributed.

(c)     Grants of Restricted Stock Units. The Committee is authorized to grant Restricted Stock Units to
Participants on the following terms and conditions:

(i)     The issuance of Shares will occur upon expiration of the restriction period specified for an Grant of
Restricted Stock Units by the Committee (or, if permitted by the Committee, as elected by the Participant). In
addition, Restricted Stock Units shall be subject to such restrictions on transferability, risk of forfeiture and other
restrictions, if any, as the Committee may impose, which restrictions may lapse at the expiration of the restriction
period or at earlier specified times (including based on achievement of performance goals and/or future service
requirements), separately or in combination, in installments or otherwise, and under such other circumstances as the
Committee may determine at the date of grant or thereafter.

(ii)     Except as otherwise determined by the Committee, upon termination of employment or service during the
applicable restriction period or portion thereof to which forfeiture conditions apply (as provided in the Grant
instrument evidencing the Restricted Stock Units), all Restricted Stock Units that are at that time subject to such
forfeiture conditions shall be forfeited; provided that the Committee may provide, by rule or regulation or in any
Grant instrument or may determine in any individual case, that restrictions or forfeiture conditions relating to
Restricted Stock Units will lapse in whole or in part, including in the event of terminations resulting from specified
causes.

(iii)     Unless otherwise determined by the Committee, dividend equivalents on the specified number of Shares covered
by a Grant of Restricted Stock Units shall be either (A) paid with respect to such Restricted Stock Units at the
dividend payment date in cash or in unrestricted Shares, or (B) deferred with respect to such Restricted Stock Units,
either as a cash deferral or with the amount or value thereof automatically deemed reinvested in additional Restricted
Stock Units, as the Committee shall determine or permit a Participant to elect.

(d)     Performance-Based Awards. The Committee may condition the grant, vesting or settlement, and the timing
thereof, of any Grant under the Plan upon the achievement or satisfaction of such performance conditions as may be
specified by the Committee during a specified Performance Period. The Committee may use such business criteria and
other measures of performance as it may deem appropriate in establishing any performance conditions, except as limited
under this Sections 8(d) in the case of Grants intended to qualify as “performance-based compensation” under Section
162(m) of the Code (“Performance Awards”). With respect to any Performance Award, the grant, vesting and/or settlement
of such award shall be contingent upon the satisfaction or achievement of one or more pre-established Performance Goals
during a specified Performance Period and shall satisfy the following requirements:

(i)     The Performance Goal or Goals shall be objective and shall otherwise meet the requirements of Section 162(m) of
the Code, including the requirement that the level or levels of performance targeted by the Committee result in the
achievement of Performance Goals being “substantially uncertain.” The Performance Goal or Goals shall consist of one or
more of the following business criteria and a targeted level or levels of performance with respect to such criteria, as
specified by the Committee:

(1)     the attainment of specified levels of, or increases in, the Company’s after-tax or pretax return on
stockholder’s equity,

(2)     the attainment of specified levels in the fair market value of the Company’s shares;

(3)     the attainment of specified levels of growth in the value of an investment in the Company’s shares;

(4)     the attainment of specified levels of, or increases in, the Company’s pre-tax or after-tax earnings, profits,
net income, or earnings per share;

(5)     the attainment of specified levels of, or increases in, the Company’s earnings before income tax, depreciation
and amortization (EBITDA);

(6)     the attainment of specified levels of, or increases in, the Company’s net sales, gross revenues or cash flow
from operations;

(7)     the attainment of specified levels of, or increases in, the Company’s working capital, or in its return on
capital employed or invested;

(8)     the attainment of specified levels of, or decreases in, the Company’s operating costs or any one or more
components thereof, or in the amount of all or any specified portion of the Company’s debt or other outstanding
financial obligations; and

(9)     the attainment of strategic business criteria, consisting of one or more objectives based on meeting specified
market penetration or value added, product development or introduction (including without limitation any regulatory or
other approvals, or other product development milestones), geographic business expansion goals, cost targets, customer
satisfaction, employee satisfaction, information technology, and goals relating to acquisitions or divestitures of
subsidiaries, affiliates or joint ventures.

 

3

 

(ii)     Any of the foregoing business criteria which the Committee utilizes in connection with the establishment of a
Performance Goal or Goals may be measured either by the performance of the Company and its wholly-owned subsidiaries on
a consolidated basis, or by the performance of any one or more of the Company’s subsidiaries, divisions, or other
business units, as the Committee in its discretion may determine. In its discretion, the Committee may also establish
Performance Goals, based on any of the foregoing business criteria, that require the attainment of a specified level of
performance of the Company, or any of its subsidiaries, divisions or other business units, relative to the performance
of other specified corporations or an index, in order for such Goals to be met. To the extent permitted by Section
162(m) of the Code, the Committee may also, in its discretion, include in any Performance Goal or Goals, the attainment
of which depends on a determination of the net earnings or income of the Company or any of its subsidiaries, divisions
or other business units, provisions which require such determination to be made by eliminating the effects of any
decreases in or charges to earnings for (A) any acquisitions, divestitures, discontinuances of business operations,
restructurings or other special charges, (B) the cumulative effect of any accounting changes, and (C) any
“extraordinary items” as determined under generally accepted accounting principles, to the extent that such decreases
or charges referred to in clauses (A) through (C) are separately disclosed in the Company’s Annual Report for each
fiscal year within the applicable Performance Period.

(iii)     At the end of a Performance Period established in connection with any Performance Award, the Committee shall
determine the extent to which the Performance Goal or Goals and any other material terms established by it for such
Performance Award have been satisfied or achieved and shall certify in writing the extent to which it has determined
that the Performance Goal or Goals and other material terms established by it for such Performance Award have been
satisfied or achieved.

9.     Conditions to Grants. The making of any Grant and the issuance of any Shares to a Participant shall be
subject to the condition that, if at any time the Company shall determine in its discretion that the satisfaction of
withholding tax or other withholding liabilities, or that the listing, registration, or qualification of any Shares
otherwise deliverable hereunder upon any securities exchange or under any state or federal law, or that the consent or
approval of any regulatory body, is necessary or desirable as a condition of, or in connection with, the delivery or
purchase of Shares pursuant hereto, then in any such event, such Grant or such issuance of Shares shall not be
effective unless such withholding, listing, registration, qualification, consent, or approval shall have been effected
or obtained free of any conditions not acceptable to the Company.

10.     Amendment, Suspension, and Termination of Plan. The Board may at any time suspend or terminate the Plan
or any portion thereof. The Board may amend the Plan from time to time in such respects as the Board may deem advisable
in order that the Grants granted hereunder may conform to any change in the law or in any other respects which the
Board may deem to be in the best interests of the Company, subject to stockholder approval of any such amendment to the
extent required by applicable law or exchange requirements. No Grants may be made during any suspension or after the
termination of the Plan. Except as provided in the Plan, no amendment, suspension, or termination of the Plan shall,
without the Participant’s consent, alter or impair any of the rights or obligations under any Grant theretofore granted
to such Participant under the Plan.

11.     Tax Withholding. The Committee may, in its sole discretion, (a) require a Participant to remit to the
Company a cash amount sufficient to satisfy, in whole or in part, any federal, state and local withholding tax
requirements prior to the delivery of any certificate for Shares pursuant to a Grant hereunder; (b) require a
Participant to satisfy, in whole or in part, any such withholding tax requirements by having the Company, upon any
delivery of Shares, withhold from such Shares that number of full Shares having a fair market value equal to the amount
or portion of the amount required or permitted to be withheld; or (c) satisfy such withholding requirements through
another lawful method.

12.     Code Section 83(b) Elections. Each Participant making an election pursuant to Section 83(b) of the Code
shall, upon the making of such election, promptly provide a copy of such election to the Company.

13.     No Employment Rights Conferred. Nothing in this Plan shall interfere with or limit in any way the right
of the Company or any of its affiliates to terminate any Participant’s employment or consulting or advisory arrangement
at any time, nor confer upon any Participant any right to continue in the employ of, or render consulting or advisory
services to, the Company or any of its affiliates.

14.     Governing Law. The validity, construction, and effect of the Plan, any rules and regulations relating
to the Plan and any Grant instrument shall be determined in accordance with the laws of the State of Delaware, without
giving effect to principles of conflicts of laws.

15.     Effective Date of the Plan. The Plan (as amended and restated herein) shall become effective on
September 16, 2008.

16.     Term. No Grants may be made under the Plan after October 16, 2010, the tenth anniversary of its
original adoption by the Board. The provisions of the Plan shall, however, continue to apply as to any Grants made
prior to such date.

 

4Filed by Bowne Pure Compliance

Exhibit 10.2

EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”), effective as of the date that the last signatory to
the Agreement signs below, is entered into by and between John Romza (“Employee”) and SXC Health
Solutions, Inc. (the “Company”).

RECITALS

A. The Company wishes to continue to employ Employee, and Employee wishes to continue to be
employed by the Company, as its Executive Vice President, Research and Development and Chief
Technology Officer, and Employee desires to continue employment with the Company under the terms
and conditions set forth in this Agreement.

B. In order to induce the Employee to enter into this Agreement, and to incentivize and reward
Employee’s continued effort, loyalty and commitment to the Company, concurrent with the execution
and delivery of this Agreement the Company expresses its intention to grant to the Employee stock
options to purchase 10,000 shares of SXC Health Solutions Corporation.

C. Employee acknowledges that as a member of the Company’s senior management team, Employee is
one of the persons charged with responsibility for the implementation of the Company’s business
plans, and that Employee is one of only a few Employees who will have regular access to
confidential and/or proprietary information relating to the Company. Further, Employee acknowledges
that Employee’s covenants to the Company hereinafter set forth are being made in partial
consideration of the Company’s willingness to employ Employee under the terms and conditions set
forth in this Agreement. As a condition of that employment, the Company requires that this
Agreement be entered into pursuant to which Employee furnishes the Company with, among other
things, certain covenants of Employee, including Employee’s covenant not to compete, not to
disclose the Company’s confidential and proprietary information and non-solicitation of employees
and customers for a reasonable period of time. Employee acknowledges that Employee’s covenants to
the Company hereinafter set forth are being made in partial consideration of the Company’s grant
stock options to purchase shares of common stock of SXC Health Solutions Corporation.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing recitals, and the mutual agreements herein
contained and other good and valuable consideration, the receipt and sufficiency of which are
hereby mutually acknowledged, the parties hereby agree as follows:

ARTICLE I

EMPLOYMENT RELATIONSHIP

1.1 Employment. Subject to the terms and conditions of this Agreement, the Company
hereby agrees to employ or continue to employ Employee to serve as Executive Vice President,
Research ad Development and Chief Technology Officer, and Employee hereby accepts such employment,
and agrees to perform his duties and responsibilities to the best of Employee’s abilities in a
diligent, trustworthy, businesslike and efficient manner.

1.2 Duties. The Employee shall be the Company’s Executive Vice President, Research and
Development and Chief Technology Officer. Employee shall be responsible for all research,
development, and information technology efforts, and such other duties as may be reasonably
requested by the Company. Employee shall report to the Company’s President and CEO. Employee
shall perform
his duties under this Agreement at the Company’s facilities in Lisle, Illinois or any subsequent
location of the Company’s primary administrative operations.

 

 

 

1.3 Exclusive Employment. While employed by the Company hereunder, Employee covenants
to the Company that he/she will devote his/her entire business time, energy, attention and skill to
the Company (except for permitted vacation periods and reasonable periods of illness or other
incapacity), and use his/her good faith best efforts to promote the interests of the Company. The
foregoing shall not be construed as prohibiting Employee from spending such time as may be
reasonably necessary to attend to Employee’s personal affairs and investments so long as such
activities do not conflict or interfere with Employee’s obligations and/or timely performance of
his/her duties to the Company.

1.4 Employee Representations and Warranties as to Employability. Employee hereby
represents and warrants to the Company that:

(a) The execution, delivery and performance by Employee of this Agreement and any other
agreements contemplated hereby to which Employee is a party do not and shall not conflict
with, breach, violate or cause a default under any contract, agreement, instrument, order,
judgment or decree to which Employee is a party or by which he/she is bound;

(b) Employee is not a party to or bound by any employment agreement, non-competition
agreement or confidentiality agreement with any other person or entity (or if a party to
such an agreement, Employee has disclosed the material terms thereof to the Board prior to
the execution hereof and promptly after the date hereof shall deliver a copy of such
agreement to the
Board);1

(c) The Company has not requested, directly or indirectly, expressly or implicitly,
that Employee use or disclose the trade secrets or other confidential information of any
prior employer or other third party, and Employee warrants that he will not use or disclose
such information;

(d) Upon the execution and delivery of this Agreement by the Company, this Agreement
shall be the valid and binding obligation of Employee, enforceable in accordance with its
terms; and

(e) Employee hereby acknowledges and represents that he/she has been given the
opportunity to consult with independent legal counsel regarding Employee’s rights and
obligations under this Agreement and that he/she fully understands the terms and conditions
contained herein.

ARTICLE II

PERIOD OF EMPLOYMENT

2.1 Employment Period. Employee’s employment hereunder shall commence on the date this
Agreement is executed, and shall continue hereunder until the date fixed by the provisions of
Section 2.2 hereof, subject to the early termination provisions of Article V hereof (the
“Employment Period”).

2.2 Initial Term of Employment Period and Extension Terms. The Employment Period shall
initially continue for a term commencing on the date this Agreement is executed, above, and ending
on June 30, 2010 (the “Initial Term”). The Employment Period shall be automatically extended for
successive one (1) calendar year periods following the expiration of the Initial Term (each period
being hereinafter referred to as an “Extension Term”) upon the same terms and conditions provided
for herein unless either party provides the other party with advance written notice of its or
Employee’s intention not to extend the Employment Period; provided, however, that such notice must
be delivered by the non-extending party to the other party not later than sixty (60) days prior to
the expiration of the Initial Term or any Extension Term, as the case may be. If the Employment
Period is not extended as a result of notice to Employee by the Company, and Employee’s employment
with the Company terminates as a result thereof, then Employee’s termination shall be a treated as
a Termination by the Company Without Cause.

 

2

 

ARTICLE III

COMPENSATION

3.1 Annual Base Compensation. During the Employment Period the Company shall pay to
Employee an annual base salary (the “Annual Base
Compensation”) in the amount of two hundred seventy thousand
and 00/100 Dollars ($270,000). The Annual Base Compensation shall be paid in regular
installments in accordance with the Company’s regular payroll practices, and shall be subject to
all required federal, state and local withholding taxes. Employee’s Annual Base Compensation shall
be reviewed annually by the Company’s Chairman and CEO and the SXC Compensation Committee, and any
such modified amount shall become the Annual Base Compensation hereunder.

3.2 Employee Incentive Compensation Bonus. In respect of each calendar year falling
within the Employment Period, Employee shall be eligible to earn an incentive compensation bonus,
depending upon the achievement of the Company’s and Employee’s performance objectives (the
“Incentive Compensation Bonus”). The amount of the Incentive Compensation Bonus shall be targeted
at sixty-five percent (65%) of the Employee’s Annual Base Compensation, with the specific
percentage determined by the Company’s Board of Directors after the close of the Company’s fiscal
year (December 31). The Incentive Compensation Bonus, if any, shall be paid to Employee at the same
time other members of the Senior Employee Team are paid their respective incentive compensation
bonuses. If the Employee’s employment terminates during the calendar year due to a Change In
Control (5.4.d) or Termination Without Cause (5.4.c), the Employee shall receive a pro rata
amount of the Incentive Compensation Bonus that Employee would have received if Employee remained
employed throughout the calendar year. If the Employee’s employment terminates during the calendar
year for any other reason, then no Incentive Compensation bonus shall be paid for that calendar
year. To the extent practicable, the Company will notify Employee of Employee’s performance
objectives for the year in January of that year.

3.3 Expenses. During the Employment Period, Employee shall be entitled to
reimbursement of all business expenses reasonably incurred in the performance of Employee’s duties
for the Company, including reasonable travel-related expenses, upon submission of all receipts and
accounts with respect thereto, and approval by the Company thereof, in accordance with the then
current business expense reimbursement policies of the Company.

3.4 Paid Time Off. Employee shall be entitled to accrue over the course of the calendar year
Paid Time Off in accordance with the Company’s then current Paid Time Off policy.

3.5 Insurance. During the Employment Period Employee shall be eligible to
participate in the Company’s insurance programs on terms and conditions no less
favorable than those made available generally to other similarly situated employees,
as such programs may be revised from time to time.

 

3

 

3.6 Retirement Plan. Employee shall be eligible to participate in the Company’s
retirement plans, including its 401(k) plan and any other plans made available to comparably
situated Employees, subject to the terms and provisions in the respective Plan Documents of such
Plans.

3.7
Grant of Stock Options.

a. Upon the commencement of the Initial Term, Employee shall be granted options
(“Options”) to purchase 10,000 shares of common stock of SXC Health Solutions Corp. The
grants of Options provided by Section 3.7(a) are contingent upon approval by SXC Health
Solutions Corp.’s Board of Directors and shareholders. The Options shall be subject to the
Company’s current Stock Option Plan. The options shall vest in one-fourth increments
annually, commencing on the anniversary date of the grant.

b. Except as otherwise provided in Section 5.2(e) of this Agreement, once vested, the
Options shall have a five (5) year life.

c. Upon a Change of Control (defined below), all of the Options shall vest.

3.8 Stock Option Plan. Employee shall be permitted to participate in the Company’s
Stock Option Plan in the same manner as the Company’s other Executive Vice Presidents, with future
annual grants based on Employee’s performance as determined by the Company’s Chief Executive
Officer.

3.9 Other Fringe Benefits. During the Employment Period, Employee shall be entitled
to receive such of the Company’s other fringe benefits as are being provided to other Executives of
the Company on the Senior Executive Team.

3.10 Vehicle Allowance. Employee shall receive a monthly payment of Five Hundred and
00/100 dollars ($500.00) for Employee’s use of a personal automobile for business use (“Vehicle
Allowance”). The Vehicle Allowance shall be subject to all required federal, state, and local
withholding.

ARTICLE IV

COVENANTS OF EMPLOYEE

4.1 Covenants Regarding Developments. Employee agrees as follows with regard to any
developments that relate to the Company’s business or Confidential and Proprietary Information
(defined below), or that Employee conceives, makes, develops or acquires, including, but not
limited to, any trade secrets, discoveries, inventions, improvements, ideas, programs, formulas,
diagrams, designs, plans and drawings, whether or not reduced to writing, patented, copyrighted or
trademarked (“Developments”):

(a) Employee shall promptly and fully disclose all Developments to the Company, and
shall prepare, maintain, and make available to the Company adequate and current written
records of such Developments and all modifications, research, and studies made or undertaken
by Employee with respect thereto.

(b) All Developments and related records shall become and remain the exclusive property
of the Company and, to the extent Employee has any rights thereto, Employee hereby assigns
all such rights, title, and interest to the Company.

 

4

 

(c) Upon request by the Company, Employee, at any time, whether during or after
Employee’s employment by the Company, shall execute, acknowledge and deliver to the Company
all assignments and other documents which the Company deems necessary or desirable to: (i)
vest the Company with full and exclusive right, title, and interest to such Developments,
and (ii) enable the Company to file and prosecute an application for, or acquire, maintain
or enforce, all letters of patent, trademark registrations, and copyrights covering such
Developments.

(d) The foregoing provisions regarding assignments do not apply to any Developments for
which no equipment, supplies, facility or trade secret information of the Company was used,
and which were developed entirely on Employee’s own time, unless the Developments: (i)
relate to the Company’s business or to its actual or demonstrably anticipated research or
development, or (ii) result from any work performed by Employee for the Company.

4.2
Ownership and Covenant to Return Documents, etc. Employee agrees that all Company
work product and all documents or other tangible materials (whether originals, copies or
abstracts), including without limitation, price lists, quotation guides, outstanding quotations,
books, records, manuals, files, sales literature, training materials, customer records,
correspondence, computer disks or print-out documents, contracts, orders, messages, phone and
address lists, invoices and receipts, and all objects associated therewith, which in any way relate
to the business or affairs of the Company either furnished to Employee by the Company or are
prepared, compiled or otherwise acquired by Employee during the Employment Period, shall be the
sole and exclusive property of the Company. Employee shall not, except for the use of the Company,
use, copy or duplicate any of the aforementioned documents or objects, nor remove them from the
facilities of the Company, nor use any information concerning them except for the benefit of the
Company, either during the Employment Period or thereafter. Employee agrees that Employee will
deliver all of the aforementioned documents and objects that may be in Employee’s possession to the
Company on the termination of Employee’s employment with the Company, or at any other time upon the
Company’s request.

4.3 Nondisclosure Covenant. Employee recognizes that by virtue of Employee’s
employment with the Company, Employee will be granted otherwise prohibited access to trade secrets
and other confidential and proprietary information that is not known to its competitors or within
the industry generally, that was developed by the Company over a long period of time and/or at
substantial expense, and which is confidential in nature or otherwise of great competitive value to
the Company. This information (“Confidential and Proprietary Information”) includes, but is not
limited to, the Company’s trade secrets; information relating to the Company’s production practices
and methods of doing business; sales, marketing, and service strategies, programs, and procedures;
contract expiration dates, customers and prospective customers, including, but not limited to,
their particularized requirements and preferences, and the identity, authority, and
responsibilities of their key contact persons; payment methods; service and product costs; pricing
structures and incentive plans; vendors; financial position and business plans; computer programs
and databases; research projects; new product and service developments; and any other information
of the Company or any of its vendors or customers that the Company informs Employee, or which
Employee should know by virtue of Employee’s position or the circumstances in which Employee
learned it, is to be kept confidential. Confidential and Proprietary Information does not include
information that is (i) in the public domain (except as a result of a breach of this Agreement or
Employee’s obligations under a statutory or common law obligation) or (ii) obtained by Employee
from a third party subsequent to the termination of Employee’s employment with the Company (except
where the third party obtains the information in violation of a contractual obligation, a statutory
or common law obligation). Employee agrees that during the Employment Period and at all times
thereafter (a) Employee will not disclose, use or permit others to use any Confidential and
Proprietary Information, or otherwise make use of any of it for Employee’s own purposes or the
purposes of another, except as required in the course of Employee’s employment for the benefit of
the Company or
as required by law, and (b) Employee will take all reasonable measures, in accordance with the
Company’s policies, procedures, and instructions, to protect the Confidential and Proprietary
Information from any accidental or unauthorized disclosure or use.

 

5

 

4.4 Noninterference Covenant. Employee agrees that during the Employment Period and
for the Restricted Period, Employee will not, for any reason, directly or indirectly solicit, hire,
or otherwise do any act or thing which may induce any other Employee of the Company (who is
employed by the Company at the end of the Employee’s employment with the Company) to leave the
employ of the Company. “Restricted Period” means (i) the Employment Period and (ii) the one (1)
year period following the termination of Employee’s employment.

4.5 Covenant of Nonsolicitation of Customers. Employee acknowledges the Company’s
legitimate interest in protecting its customers for a reasonable period of time following the
termination of Employee’s employment. Accordingly, Employee agrees that during the Restricted
Period, Employee will not: (a) directly or indirectly, solicit or accept business from, or provide
products or services to, any Customer, where such business, products or services would be
competitive with the Company’s business, products or services, or (b) do any act or thing which may
interfere with or adversely affect the relationship (contractual or otherwise) of the Company with
any Customer or vendor of the Company or induce any such Customer or vendor to cease doing business
with the Company. For purposes of this paragraph, the term “Customer” means (i) a customer of the
Company to which Employee sold or provided the Company’s products or services at any time during
the two (2) year period immediately preceding the termination of Employee’s employment, (ii) any
entity for which Employee orchestrated, developed, supervised, coordinated or participated in
marketing strategy, marketing plans and marketing campaigns on behalf of the Company at any time
during the two (2) year period immediately preceding the termination of Employee’s employment, or
(iii) any entity as to which Employee acquired Confidential and Proprietary Information at any time
during Employee’s employment with the Company.

4.6. Covenant Not To Compete. Employee expressly acknowledges that (i) the Company is
and will be engaged in the business of providing pharmacy benefit management services, healthcare
transaction processing services, and information technology solutions to the pharmaceutical
industry, including without limitation: (x) pharmacy benefit services and analytics software and
related ASP services, including claims processing, pharmacy networks, data warehousing and
information analysis, rebate contracting and formulary management, clinical initiatives, mail order
pharmacy services, and consumer web services; (y) pharmacy practice management and point of
sale(POS) systems for retail pharmacy (independents and chains); institutional/nursing home
pharmacy, and high-volume mail order pharmacy; and (z) specialty pharmacy products and services;
(ii) Employee is one of a limited number of persons who has extensive knowledge and expertise
relevant to the businesses of the Company; (iii) Employee’s performance of his services for the
Company hereunder will afford Employee full and complete access to and cause Employee to become
highly knowledgeable about the Company’s Confidential and Proprietary Information; (iv) the
agreements and covenants contained in this section 4.6 are essential to protect the business and
goodwill of the Company, because, if Employee enters into any activities competitive with the
businesses of the Company, Employee will cause substantial harm to the Company; (v) Employee will
be exposed to the Company’s largest customers; (vi) the business territory of the Company at the
time this Agreement was entered into constitutes the United States and Canada (the “Business
Territory”); and (vii) Employee’s covenants to the Company set forth in this section 4.6 are being
made in consideration of the Company’s willingness to employ him. Accordingly, Employee hereby
agrees that during the Restricted Period, Employee shall not, within the Business Territory,
directly or indirectly own any interest in, invest in, lend to, borrow from, manage, control,
participate in, consult with, become employed by, render services to, or in any other manner
whatsoever engage in any business which is competitive with any business actively being engaged in
by the Company or actively (and demonstrably) being considered by the Company for entry into on the
date of the termination of
Employee’s employment with the Company. The preceding to the contrary notwithstanding, Employee
shall be free to make investments in the publicly traded securities of any corporation, provided
that such investments do not amount to more than 1% of the outstanding securities of any class of
such corporation.

 

6

 

4.7 Remedies for Breach. Employee recognizes that the rights and privileges granted to
Employee by this Agreement, and Employee’s corresponding covenants to the Company, are of a
special, unique, and extraordinary character, the loss of which cannot reasonably or adequately be
compensated for in damages in any action at law or through the offset or withholding of any monies
to which Employee might be entitled from the Company. Accordingly, Employee understands and agrees
that the Company shall be entitled to equitable relief, including a temporary restraining order and
preliminary and permanent injunctive relief, to prevent or enjoin a breach of this Agreement.
Employee also understands and agrees that any such equitable relief shall be in addition to, and
not in substitution for, any other relief to which the Company may be entitled.

ARTICLE V

TERMINATION

5.1 Termination and Triggering Events. Notwithstanding anything to the contrary
elsewhere contained in this Agreement, the Employment Period shall terminate at the expiration of
the Initial Term or any Extension Term upon notice as provided in Section 2.2, or prior to the
expiration of the Initial Term or any Extension Term upon the occurrence of any of the following
events (individually referred to as a “Triggering Event”): (a) Employee’s death; (b) Employee’s
Total Disability; (c) Employee’s Resignation; (d) Termination by the Company for Cause; (e)
Termination by the Company Without Cause; or (f) Termination Arising Out of a Change of Control.

5.2 Rights Upon Occurrence of a Triggering Event. Subject to the provisions of Section
5.3 hereof, the rights of the parties upon the occurrence of a Triggering Event prior to the
expiration of the Initial Term or any Extension Term shall be as follows:

(a) Death, Total Disability, Resignation, and Termination by the Company for
Cause. If the Triggering Event was Employee’s Death, Total Disability (defined below),
Resignation, or a Termination by the Company for Cause (defined below), then Employee shall
be entitled to receive Employee’s Annual Base Compensation and accrued but unused vacation
time through the date of the Triggering Event, and to continue to participate in the
Company’s employee welfare plans and programs (including, without limitations, health
insurance plans) through the date of the Triggering Event and, thereafter, only to the
extent permitted under the terms of such plans and programs.

(b) Termination by Company Without Cause. If the Triggering Event was a
Termination by the Company Without Cause, then Employee shall be entitled to receive
(i) Employee’s Annual Base Compensation and accrued but unpaid vacation through the date
thereof; (ii) payment of Employee’s Incentive Compensation Bonus, if any, pro rated to the
Employee’s date of termination (payable at the same time other members of the Senior
Executive Team are paid their respective incentive compensation bonuses which shall be in no
event later than March 15 following the close of the Company’s fiscal year); and (iii) the
Severance Benefit. “Severance Benefit” means a payment equal to the Employee’s Annual Base
Compensation as of the date of termination, payable according to the Company’s regular
payroll schedule, less required tax withholding, commencing within thirty (30) days from the
date the Company receives the Separation and Release Agreement executed by Employee. For
purposes of this subsection 5.2(b), any payment or benefit that the Employee receives shall
be treated as a “separate payment” for the application of Section 409A of the Internal
Revenue Code (“Code”). Employee’s entitlement to the benefits provided in subsections 5.2(b)(ii) and (iii) are
contingent on Employee signing a Separation Agreement and General Release provided by the
Company. The Company intends to rely on the involuntary separation from service exception of
Treasury regulation §1.409A-1(b)(9)(iii) if the Employee receives any payment or benefit due
to his Termination by the Company Without Cause.

 

7

 

(c) Termination Arising Out of a Change of Control. If the Triggering Event was
a Termination Arising Out of a Change of Control (defined below), then Employee shall be
entitled to receive (i) Employee’s Annual Base Compensation and accrued but unpaid vacation
through the date thereof; (ii) payment of a Employee’s Incentive Compensation Bonus, if any,
pro rated to Employee’s date of termination (payable at the same time other members of the
Senior Executive Team are paid their respective incentive compensation bonuses which shall
be in no event later than March 15 following the close of the Company’s fiscal year); and
(iii) the Change of Control Severance Benefit. Employee’s entitlement to the benefits
provided in subsections 5.2(c)(ii) and (iii) is contingent on Employee signing a Separation
Agreement and General Release provided by the Company within a reasonable period of time
following the date the Separation Agreement and General Release is provided to Employee.
“Change of Control Severance Benefit” means a lump-sum payment, less required tax
withholding, equal to two times the Employee’s Annual Base Compensation at the time of
termination, plus one (1) times Employee’s Incentive Compensation Target at the time of
Employee’s termination. The Change of Control Severance Benefit shall be paid within thirty
(30) days from the date the Separation and Release Agreement, executed by Employee, is
received by the Company. Notwithstanding the foregoing to the contrary, if the Compensation
Committee determines that the Employee is a Specified Employee then his Change of Control
Severance Benefit due under this paragraph (c) shall be made no earlier than the six (6)
month anniversary of the Triggering Event or upon the death of the Employee, if earlier,
pursuant to Section 409A of the Code. Notwithstanding anything to the contrary contained in
this Agreement, if and to the extent that any payments and rights provided under this
Agreement would cause Employee to be subject to excise tax under Section 280G or Section
4999 of the Code, or the corresponding section(s) of any future federal tax law, then the
amount of payments shall be reduced to the extent necessary to avoid imposition of any such
excise tax.

(d) Cessation of Entitlements and Company Right of Offset. Except as otherwise
expressly provided herein, all of Employee’s rights to salary, Employee benefits, fringe
benefits and bonuses hereunder (if any) which would otherwise accrue after the termination
of the Employment Period shall cease upon the date of such termination. The Company may
offset any loans, cash advances or fixed amounts which Employee owes the Company against any
amounts it owes Employee under this Agreement.

(e) Treatment of Options. Employee may be required to exercise any vested
options within ninety (90) days from date of the termination of his employment.

5.3 Survival of Certain Obligations. The provisions of Articles IV and VI shall
survive any termination of the Employment Period, whether by reason of the occurrence of a
Triggering Event or the expiration of the Initial Term or any Extension Term.

 

8

 

5.4 Definitions. For purposes of Article V, the following definitions apply:

(a) “Resignation” means a voluntary termination of Employee’s employment with the
Company, including Employee’s declining of continued employment in the same or comparable
position with the Company following a Change of Control.

(b) “Specified Employee” means an employee who, as of the date of the employee’s
Triggering Event, is a Key Employee of the Company. For purposes herein, an employee is a
“Key Employee” if he or she satisfies the requirements of Sections 416(i)(1)(A)(i), (ii), or
(iii) of the Code (applied in accordance with applicable Treasury regulations and
disregarding Section 416(i)(5) of the Code) at any time during the 12-month period ending on
any specified employee identification date.

(c) “Termination by the Company for Cause” means termination by the Company of
Employee’s employment for:

(i) The failure of Employee to comply with any of the material provisions of
this Agreement, other than an isolated, insubstantial or inadvertent action not
taken in bad faith and which is remedied by Employee within thirty (30) days after
receipt of written notice thereof given by the Company;

(ii) A conviction of Employee by a court of competent jurisdiction of a felony;

(iii)  The refusal, failure or neglect of Employee to perform his duties under
his employment agreement in a manner that is materially detrimental to the business
or reputation of the Company unless remedied by Employee within thirty (30) days
after receipt of written notice thereof given by the Company;

(iv) The engagement by the Employee in illegal, unethical or other wrongful
conduct that is materially detrimental to the business or reputation of SXC; or

(v) The pursuit by Employee of interests that are materially adverse to SXC
unless remedied by Employee within thirty (30) days after receipt of written notice
thereof given by the Company;

(d) “Termination by the Company Without Cause” means a termination of Employee’s
employment by the Company which is not a Termination by the Company for Cause, provided that
the termination of the Employment Period on account of the failure of the Company to extend
the Employment Period in accordance with the provisions of Section 2.2 hereof shall
constitute a Termination by the Company Without Cause.

(e) A “Termination Arising Out of a Change of Control” means, following a Change of
Control (defined below), Employee is not offered or retained in his current or a comparable
position. A “Change of Control” shall be defined under this Agreement to mean any of the
following occurrences:

(i) Any person, other than SXC Health Solutions Corp. or an employee benefit
plan of SXC Health Solutions Corp. or the Company, acquires directly or indirectly
the Beneficial Ownership (as defined in Section 13(d) of the Securities Exchange Act
of 1934, as amended) of any voting security of SXC Health Solutions Corp. and
becomes, immediately after and as a result of such acquisition, directly or
indirectly, the Beneficial Owner of voting securities representing 50% or more of
the total voting power of all of the then-outstanding voting securities of SXC
Health Solutions Corp.;

 

9

 

(ii) The shareholders of SXC Health Solutions Corp. approve a merger, and
such merger is completed, consolidation, recapitalization, or reorganization of SXC
Health Solutions Corp. or the Company, a reverse stock split of outstanding voting
securities, or consummation of any such transaction if shareholder approval is not
sought or obtained, other than any such transaction that would result in at least
75% of the total voting power represented by the voting securities of the surviving
entity outstanding immediately after, and as a result of such transaction, being
Beneficially Owned by at least 75% of the holders of outstanding voting securities
of SXC Health Solutions Corp. immediately prior to the transaction, with the voting
power of each such continuing holder relative to other such continuing holders not
substantially altered in the transaction; or

(iii) The shareholders of SXC Health Solutions Corp. approve a plan of
complete liquidation of SXC Health Solutions Corp. or the Company or an agreement
for the sale or disposition by SXC Health Solutions Corp. of all or a substantial
portion of assets (i.e., 50% or more) of the total assets of SXC Health Solutions
Corp. or the Company.

(f) “Total Disability” means the Employee (i) is unable to engage in any substantial
gainful activity by reason of any medically determinable physical or mental impairment which
can be expected to result in death or can be expected to last for a continuous period of not
less than 12 months, or (ii) is by reason of any medically determinable physical or mental
impairment which can be expected to result in death or can be expected to last for a
continuous period of not less than 12 months, receiving income replacement benefits for a
period of not less than three months under an accident and health plan which covers the
Employee. Subject to the provisions of Section 409A and the Treasury regulations issued
thereunder, any determination of whether the Employee satisfies the definition of “Total
Disability” shall be made by the Compensation Committee, based upon the medical evidence
from a physician selected by the Compensation Committee. Any determination of whether the
Employee satisfies the definition of “Total Disability” for purposes of this Agreement shall
not be construed as a determination for any other purpose.

ARTICLE VI

GENERAL

6.1 Governing Law. This Agreement shall be subject to and governed by the laws of the
State of Illinois without regard to any choice of law or conflicts of law rules or provisions
(whether of the State of Illinois or any other jurisdiction), irrespective of the fact that
Employee may become a resident of a different state.

6.2 Binding Effect. The Agreement shall be binding upon and inure to the benefit of
the Company, its successors and assigns, and Employee and Employee’s executors, administrators,
personal representatives and heirs.

6.3 Assignment. Employee expressly agrees for Employee and on behalf of Employee’s
executors, administrators and heirs, that this Agreement and Employee’s obligations, rights,
interests and benefits hereunder shall not be assigned, transferred, pledged or hypothecated in any
way by Employee, Employee’s executors, administrators or heirs, and shall not be subject to
execution, attachment or similar process. Any attempt to assign, transfer, pledge, hypothecate or
otherwise dispose of this Agreement or any such rights, interests and benefits hereunder contrary
to the foregoing provisions, or the levy of any
attachment or similar process thereupon shall be null and void and without effect and shall relieve
the Company of any and all liability hereunder. This Agreement shall be assignable and transferable
by the Company (but the Company shall not be required to assign or transfer this Agreement) to any
successor in interest without the consent of Employee.

 

10

 

6.4 Complete Understanding. This Agreement constitutes the complete understanding
among the parties hereto with regard to the subject matter hereof, and supersedes any and all prior
agreements and understandings relating to the employment of Employee by the Company, including
without limitation any prior compensation plans or compensation agreements entered into between
Employee and the Company.

6.5 Tax Provisions.

(a) Compliance With Section 409A of the Code. To the extent applicable, it is
intended that this Agreement comply with the provisions of section 409A of Internal Revenue Code of
1986 (the “Code”), so as to prevent the inclusion in gross income of any amounts payable or
benefits provided hereunder in a taxable year that is prior to the taxable year or years in which
such amounts or benefits would otherwise actually be distributed, provided or otherwise made
available to Employee. This Agreement shall be construed, administered, and governed in a manner
consistent with this intent. Any provision that would cause any amount payable or benefit provided
under this Agreement to be includable in the gross income of Employee under Code section 409A(a)(1)
shall have no force and effect unless and until amended to cause such amount or benefit to not be
so includable (which amendment may be retroactive to the extent permitted by Code section 409A and
may be made by Company without the consent of Employee). In particular, to the extent Employee
becomes entitled to receive a payment or a benefit upon an event that does not constitute a
permitted distribution event under Code section 409A(a)(2), then notwithstanding anything to the
contrary in this Agreement, such payment or benefit will be made or provided to Employee on the
earlier of (i) Employee’s “separation from service” with Company (determined in accordance with
Code section 409A); provided however, that if Employee is a “specified Employee” (within the
meaning of Code section 409A), Employee’s date of payment shall be made on the date which is 6
months after the date of Employee’s separation of service with Company or (ii) Employee’s death.
Any reference in this Agreement to Code section 409A shall also include any proposed, temporary or
final regulations, or any other guidance, promulgated with respect to such section by the U.S.
Department of the Treasury or the Internal Revenue Service.

(b) Compliance With Section 162(m) of the Code. Notwithstanding anything herein to
the contrary, if the Company reasonably anticipates that the deduction of any payment to Employee
hereunder will be limited or eliminated by the application of Code section 162(m), which generally
limits the deduction of compensation paid by public corporations in excess of $1 million annually
to certain executives, such payment shall be delayed until the earliest date at which the Company
reasonably anticipates that the deduction of the payment would not be limited or eliminated by the
application of Code section 162(m) or the calendar year during which the Employee’s employment with
the Company terminates.

6.6 Amendments. No change, modification or amendment of any provision of this
Agreement shall be valid unless made in writing and signed by all of the parties hereto.

6.7 Waiver. The waiver by the Company of a breach of any provision of this Agreement
by Employee shall not operate or be construed as a waiver of any subsequent breach by Employee. The
waiver by Employee of a breach of any provision of this Agreement by the Company shall not operate
as a waiver of any subsequent breach by the Company.

 

11

 

6.8 Venue, Jurisdiction, Etc. Employee hereby agrees that any suit, action or
proceeding relating in any way to this Agreement shall be brought and enforced in the Eighteenth
Judicial Circuit, DuPage County, State of Illinois or in the District Court of the United States of
America for the Northern District of Illinois, Eastern Division, and in either case Employee hereby
submits to the jurisdiction of each such court. Employee hereby waives and agrees not to assert, by
way of motion or otherwise, in any such suit, action or proceeding, any right of removal, any claim
that Employee is not personally subject to the jurisdiction of the above-named courts, that the
suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit,
action or proceeding is improper. Employee consents and agrees to service of process or other legal
summons for purpose of any such suit, action or proceeding by registered mail addressed to Employee
at Employee’s address listed in the business records of the Company. Employee and the Company do
each hereby waive any right to trial by jury, Employee or it may have concerning any matter
relating to this Agreement.

6.9 Indemnification of Employee. Employee is hereby entitled to indemnification for
Employee’s acts or omissions in Employee’s capacity as an Employee or officer of the Company to the
same extent as the Company’s other senior Employees and in the manner provided by the Company’s
bylaws.

6.10 Directors and Officers Liability Insurance. The Company shall maintain adequate
Directors and Officers liability insurance coverage, which shall include Employee in Employee’s
capacity as an Officer. The adequacy of the Directors and Officers liability insurance coverage
shall be determined annually by the Board of Directors at its reasonable discretion.

6.11 Severability. If any portion of this Agreement shall be for any reason, invalid
or unenforceable, the remaining portion or portions shall nevertheless be valid, enforceable and
carried into effect.

6.12 Headings. The headings of this Agreement are inserted for convenience only and
are not to be considered in the construction of the provisions hereof.

 

12

 

6.13 Notices. All notices under this Agreement shall be in writing and shall be deemed
properly sent, (i) when delivered, if by personal service or reputable overnight courier service,
or (ii) when received, if sent by certified or registered mail, postage prepaid, return receipt
requested to the recipient at the address indicated below or otherwise subsequently provided by one
party to the other party:

Notices to Employee:

John Romza

2104 Yale Ave.

Arlington Heights, IL. 60004

Notices to Company:

SXC Health Solutions, Inc.

Attn: Chief Executive Officer

2441 Warrenville Road, Suite 610

Lisle, IL. 60532-3642

6.14 Counterparts. This Agreement may be executed in one or more counterparts, all of
which, taken together, shall constitute one and the same agreement.

	 	 	 	 	 	 	 	 	 	 	 
	COMPANY:	 	EMPLOYEE:
	SXC HEALTH SOLUTIONS, INC.	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By: 	/s/ Jeffrey Park 	11/6/08	 	By: 	/s/ John Romza	 	11/6/08
	 	 	 	 	 
	 

	Its: 	Chief Financial Officer	Date
	 	 	John Romza
	 	Date

 

13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]